NFX — Nuformix Share News
0.000.00%
Last trade - 00:00Brief: Nuformix Announces Appointment Of Tim Metcalfe As Non-Executive Chairman
Appointment of Chairman
NXP002 Development Update
Half Year Report
£1.0 million Placing
Brief: Nuformix Says FDA Grants Orphan Drug Designation For Co's NXP002 In IPF
Brief: Nuformix Announces All Resolutions Passed At AGM
Posting of Annual Report and Notice of AGM
Annual Results for period ended 30 September 2025
Results of Underwritten Open Offer
Underwritten Open Offer
European Respiratory Society Congress Attendance
Brief: Nuformix Confirms In Discussions For NXP002 Licensing With A Number Of Potential Partners
Confirmation of European ODD for NXP002
£210,000 Placing
Attendance at American Thoracic Society Congress
Half-year Report
Brief: Nuformix Announces Confirmation Of European Orphan Drug Designation
Confirmation of European Orphan Drug Designation